Research

Life Sciences & Biotechnology

Title :

Development of small molecular inhibitor specifically targeting MTORC2 for cancer therapeutics: Development of targeted anti-cancer strategy

Area of Research :

Life Sciences & Biotechnology, Medical Sciences

Focus Area :

Cancer therapeutics

Principal Investigator :

Dr. Smrati Bhadauria, Scientist, Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh

Contact info :

Timeline Start Year :

2017

Total Budget (INR):

 40,83,200

Details

Organizations involved

Implementing Agency :

Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh

Funding Agency :

Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India

Related Research

Morphological and molecular study of freshwater Crabs in Mizoram, Northeast India
Assessment of Prevalence of Chronic Kidney Disease, its associated causative factors and therapeutic efficacy of herbal medicine used traditionally in Bargarh District, Odisha
Development of non-covalent dual inhibitors against pan-coronavirus MPro and PLPro proteases- Addressing the drug resistance and preparation for the future
Development of nanotherapeutic systems for siRNA or AsO based inhibition of sNHG5 lncRNA in Pancreatic Ductal Adenocarcinoma
A comprehensive assessment of nickel uptake in Cherry tomato (Lycopersicon esculentum Mill.), through study of cell death, gene interaction, epigenetic changes and analysis of ameliorating capacities of a designed "Cerium-silica nanocomposite” using stress training principles.